İrem UZUN -TDO- The World Health Organization said on Tuesday that some treatments appear to be limiting the severity or length of the COVID-19 disease and that it was focusing on learning more about four or five of the most promising ones. “We do have some treatments that seem to be in very early studies limiting the severity or the length of the illness, but we do not have anything that can kill or stop the virus,” spokeswoman Margaret Harris told a briefing. “We do have potentially positive data coming out, however we need to see more data to be 100% confident that we can say this treatment over that one,” she added, according to the Reuters.
Speaking in a briefing on Tuesday, Harris did not name the treatment. However, Gilead Science Inc, a research-based American biopharmaceutical company, says its antiviral drug called “Remdesivir” helps to improve outcomes for COVID-19 patients. Clinical data released last month on Remdesivir raised hopes that it might be an effective treatment. Several studies looking at combinations of antiviral medicines have also suggested they may help patients to fight with the virus.
Harris also said that the America continent were the current "center" of the pandemic, although she also noted rising cases in Africa. However, she said the continent had a "big advantage" over other countries with little experience of infectious disease outbreaks. The U.S. reports more infections and fatalities than any other country, with over 1.3 million cases of the virus and over 81,000 deaths.